Today: 7 February 2026
Subscribe
Browse Category

NYSE:KVUE News 25 December 2025 - 21 January 2026

Kenvue stock steadies as Kimberly-Clark deal vote nears, with lawsuits in the mix

Kenvue stock steadies as Kimberly-Clark deal vote nears, with lawsuits in the mix

Kenvue shares slipped 0.1% to $17.58 early Wednesday as investors await a January 29 shareholder vote on Kimberly-Clark’s $40 billion acquisition offer. Lawsuits and proxy disputes have surfaced ahead of the vote. Kimberly-Clark shares traded at $101.44. ISS recommended approval but flagged litigation risks and tepid market reaction.
21 January 2026
····
Kenvue stock ticks up as investors size up Kimberly-Clark takeover vote in days

Kenvue stock ticks up as investors size up Kimberly-Clark takeover vote in days

New York, Jan 20, 2026, 11:04 AM EST — Regular session ongoing. Kenvue shares ticked up 0.6% to $17.31 in late-morning trading Tuesday in New York, a modest gain as investors held back ahead of a late-January vote on the potential sale of the Tylenol and Band-Aid maker to Kimberly-Clark. The next nine days are critical since the deal stands as the clearest near-term driver for Kenvue’s stock. Investors are pricing the shares almost like a vote on the likelihood of the merger closing—and what the company’s value might be if the transaction stalls or falls through. (SEC) Kenvue shareholders
20 January 2026
·····
Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

Johnson & Johnson stock heads into earnings after a mild dip — what could move JNJ next

New York, Jan 18, 2026, 10:37 EST — Market closed. Johnson & Johnson shares slipped 0.4% to $218.66 on Friday, the last session before U.S. markets shut for the Martin Luther King Jr. Day holiday. (Yahoo Finance) The stock heads into the week with investors leaning hard on earnings to justify valuations. “The most important thing right now is earnings,” said Chris Fasciano, chief market strategist at Commonwealth Financial Network. (Reuters) On Friday, U.S. stocks ended nearly flat in choppy trade, while the S&P 500 health care sector fell 0.8%, a bigger drop than the broader market. “We’re at the
18 January 2026
··········
Kenvue stock has a new catalyst: ISS backs Kimberly-Clark merger ahead of Jan. 29 vote

Kenvue stock has a new catalyst: ISS backs Kimberly-Clark merger ahead of Jan. 29 vote

New York, Jan 18, 2026, 05:48 EST — Market closed Kenvue (KVUE) shares slipped 0.35% to close at $17.20 on Friday, as investors digested a crucial nod for its planned sale to Kimberly-Clark. Proxy adviser Institutional Shareholder Services gave the green light, saying “on balance, support for the transaction is warranted.” Still, ISS flagged ongoing market jitters and legal risks as key concerns for shareholders. With proxy advisers often influencing big institutional votes, both companies’ investors are set to weigh in on Jan. 29. (Reuters) The timing is tight and inconvenient. U.S. stock markets are closed for the weekend and
18 January 2026
·····
Kenvue stock: ISS backs Kimberly-Clark deal as lawsuit filings add pressure ahead of vote

Kenvue stock: ISS backs Kimberly-Clark deal as lawsuit filings add pressure ahead of vote

New York, Jan 17, 2026, 07:00 (EST) — Market closed. Kenvue Inc shares ended slightly lower on Friday after proxy adviser ISS backed Kimberly-Clark’s takeover proposal, keeping attention on a shareholder vote later this month. The broader market went into the long weekend on a quiet note, with the S&P 500 down 0.06% on Friday. U.S. stock markets are closed on Monday for the Martin Luther King Jr. holiday. (Reuters) ISS said “support for the transaction is warranted,” while flagging what it called a “sustained negative market reaction” and uncertainty tied to litigation around Kenvue products. Kimberly-Clark proposed buying Tylenol-maker
17 January 2026
·····
Kenvue stock is up today — here’s what the Kimberly-Clark deal is worth now

Kenvue stock is up today — here’s what the Kimberly-Clark deal is worth now

New York, January 15, 2026, 11:16 EST — Regular session. Kenvue Inc shares rose about 0.5% to $17.21 on Thursday, as Kimberly-Clark — the would-be buyer — gained roughly 0.7% to $99.81, lifting the implied value of the takeover offer. The broader market was firmer, with the S&P 500’s main ETF up about 0.6%, while the consumer staples ETF was little changed. This matters now because KVUE has been trading like a deal stock. The cash part is fixed, but the stock part moves every time Kimberly-Clark moves. It leaves investors focused on the “spread” — the gap between Kenvue’s
15 January 2026
·····
Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching

Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching

New York, Jan 14, 2026, 11:12 EST — Regular session Kenvue Inc shares ticked up roughly 0.4% to $17.08 on Wednesday, continuing a stretch of modest fluctuations as the stock moves mainly on deal speculation. The gain followed Kimberly-Clark’s submission of extra documents to the U.S. Securities and Exchange Commission related to its intended purchase of the consumer health firm. Timing is key. Kenvue shareholders will vote on the deal on Jan. 29 at 9:00 a.m. ET, with most ballots expected by the night before, per the deal site. (leadinghealthandwellness.com) Under the deal, Kenvue shareholders will get $3.50 in cash
14 January 2026
······
Kenvue stock (KVUE) ends week lower as Jan. 29 Kimberly-Clark deal vote nears

Kenvue stock (KVUE) ends week lower as Jan. 29 Kimberly-Clark deal vote nears

New York, January 11, 2026, 18:45 EST — Market closed Kenvue Inc shares slipped on Friday, closing down about 1% at $16.83, as traders headed into the weekend still pricing in a gap to Kimberly-Clark’s takeover terms. Kimberly-Clark shares ended down about 1% at $97.92. That gap has a date attached now. Stockholders of both companies are set to vote on the deal on Jan. 29 in separate virtual meetings, according to a joint proxy statement. Kenvue holders would receive $3.50 in cash and 0.14625 Kimberly-Clark shares per Kenvue share, a payout that rises or falls with Kimberly-Clark’s stock; Kenvue’s
12 January 2026
·····
Kenvue stock countdown: Jan. 29 merger vote looms as KVUE deal spread stays jumpy

Kenvue stock countdown: Jan. 29 merger vote looms as KVUE deal spread stays jumpy

NEW YORK, Jan 10, 2026, 08:01 (ET) — Market closed Kenvue Inc (KVUE) shares slipped 0.9% on Friday, ending at $16.83 after trading between $16.75 and $17.05, retracing some of Thursday’s gains. The Options Clearing Corporation highlighted a shareholder vote set for Jan. 29 on Kenvue’s proposed merger with Kimberly-Clark and detailed a planned adjustment to KVUE options once the deal closes. They warned terms might shift as new details emerge. (InfoMemo) Markets closed over the weekend, but KVUE is once again behaving like a deal stock. The key date ahead is the Jan. 29 vote, while merger-arbitrage funds keep
10 January 2026
·····
Kenvue stock: Options memo spotlights Jan. 29 vote on Kimberly-Clark deal

Kenvue stock: Options memo spotlights Jan. 29 vote on Kimberly-Clark deal

New York, January 9, 2026, 21:05 EST — Market closed. The Options Clearing Corporation on Friday announced a planned adjustment for Kenvue Inc. options before the Jan. 29 shareholder vote on the company’s proposed merger with Kimberly-Clark. Kenvue shares last changed hands at $16.83, slipping roughly 1% after U.S. markets closed. (InfoMemo) Why it matters now: Kenvue (KVUE) has become a merger-arbitrage play, with investors valuing the stock based on the offer price and the likelihood the deal goes through. The OCC memo dives into that trade but also clarifies what options contracts would actually deliver if the merger closes
10 January 2026
·····
Kenvue (KVUE) stock nudges up as fresh deal scrutiny hits — and the spread traders are watching

Kenvue (KVUE) stock nudges up as fresh deal scrutiny hits — and the spread traders are watching

New York, Jan 8, 2026, 10:57 EST — Regular session Kenvue Inc shares rose 0.8% to $16.87 in mid-morning trade on Thursday after shareholder law firm Kahn Swick & Foti said it was investigating the consumer health group’s pending sale to Kimberly-Clark. The firm said it is reviewing whether Kenvue’s board ran a fair process and secured the best price for shareholders. PR Newswire The move matters now because Kenvue’s stock has been trading like a deal situation, not a stand-alone story, as investors handicap closing odds and timing. Merger arbitrage — buying the target while hedging the buyer —
8 January 2026
·····
Kenvue Stock (NYSE: KVUE) News Today: Kimberly-Clark Deal Update, Insider Buying, Analyst Forecasts — December 25, 2025

Kenvue Stock (NYSE: KVUE) News Today: Kimberly-Clark Deal Update, Insider Buying, Analyst Forecasts — December 25, 2025

U.S. markets are closed for Christmas Day (December 25, 2025), but investors aren’t exactly “off the clock” when it comes to Kenvue Inc. (NYSE: KVUE). The former Johnson & Johnson consumer-health spinout has become a live merger-arbitrage story after Kimberly-Clark agreed to buy it, and KVUE’s price action is now a referendum on deal timing, legal risk, and whether the takeover terms hold up through 2026. As of the most recent close (Wednesday, December 24), KVUE finished at $17.21, up 1.12%, with ~14.1 million shares traded—well below its recent average volume. MarketWatch Below is what’s on the tape for December
25 December 2025
······
1 2 3

Stock Market Today

Westpac share price slides after ASX rout; investors brace for next week’s WBC update

Westpac share price slides after ASX rout; investors brace for next week’s WBC update

7 February 2026
Westpac shares fell 1.2% to A$39.43 Friday as the S&P/ASX 200 dropped 2% amid broad selling. The bank is set to roll out Microsoft 365 Copilot to 35,000 staff after a pilot last year. Investors are watching for signs of loan growth and credit quality ahead of Westpac’s first-quarter update on Feb. 13. The Reserve Bank of Australia raised its cash rate to 3.85% this week.
ANZ share price fell Friday — here’s what to watch before the ASX reopens

ANZ share price fell Friday — here’s what to watch before the ASX reopens

7 February 2026
ANZ shares closed at A$37.01 on Friday, down 1.52% as the S&P/ASX 200 fell 2% and nearly $70 billion was wiped from the market. The Reserve Bank of Australia raised its cash rate by 0.25 points to 3.85%, prompting ANZ to lift variable home loan rates from Feb. 13. ANZ announced a new Salesforce-based AI CRM rollout and a board change effective Feb. 8. Investors await ANZ’s first-quarter update on Feb. 12.
Go toTop